» Articles » PMID: 36695822

Nephron Deficit and Low Podocyte Density Increase Risk of Albuminuria and Glomerulosclerosis in a Model of Diabetes

Overview
Journal Physiol Rep
Specialty Physiology
Date 2023 Jan 25
PMID 36695822
Authors
Affiliations
Soon will be listed here.
Abstract

Podocytes are terminally differentiated epithelial cells in glomeruli. Podocyte injury and loss are features of many diseases leading to chronic kidney disease (CKD). The developmental origins of health and disease hypothesis propose an adverse intrauterine environment can lead to CKD later in life, especially when a second postnatal challenge is experienced. The aim of this study was to examine whether a suboptimal maternal environment would result in reduced podocyte endowment, increasing susceptibility to diabetes-induced renal injury. Female C57BL/6 mice were fed a low protein diet (LPD) to induce growth restriction or a normal protein diet (NPD) from 3 weeks before mating until weaning (postnatal Day 21, P21) when nephron and podocyte endowment were assessed in one male and one female offspring per litter. Littermates were administered streptozotocin or vehicle at 6 weeks of age. Urinary albumin excretion, glomerular size, and podometrics were assessed following 18 weeks of hyperglycemia. LPD offspring were growth restricted and had lower nephron and podocyte number at P21. However, by 24 weeks the podocyte deficit was no longer evident and despite low nephron endowment neither albuminuria nor glomerulosclerosis were observed. Podocyte number was unaffected by 18 weeks of hyperglycemia in NPD and LPD offspring. Diabetes increased glomerular volume reducing podocyte density, with more pronounced effects in LPD offspring. LPD and NPD diabetic offspring developed mild albuminuria with LPD demonstrating an earlier onset. LPD offspring also developed glomerular pathology. These findings indicate that growth-restricted LPD offspring with low nephron number and normalized podocyte endowment were more susceptible to alterations in glomerular volume and podocyte density leading to more rapid onset of albuminuria and renal injury than NPD offspring.

Citing Articles

Early-life exposures and long-term health: adverse gestational environments and the programming of offspring renal and vascular disease.

Oulerich Z, Sferruzzi-Perri A Am J Physiol Renal Physiol. 2024; 327(1):F21-F36.

PMID: 38695077 PMC: 11687964. DOI: 10.1152/ajprenal.00383.2023.


Associations of MRI-derived kidney volume, kidney function, body composition and physical performance in ≈38 000 UK Biobank participants: a population-based observational study.

Cho J, Koh J, Kim S, Lee S, Kim Y, Cho S Clin Kidney J. 2024; 17(4):sfae068.

PMID: 38660121 PMC: 11040514. DOI: 10.1093/ckj/sfae068.


Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes.

Gazzard S, van der Wolde J, Haruhara K, Bertram J, Cullen-McEwen L Physiol Rep. 2023; 11(2):e15579.

PMID: 36695822 PMC: 9875819. DOI: 10.14814/phy2.15579.

References
1.
Kaverina N, Eng D, Miner J, Pippin J, Shankland S . Parietal epithelial cell differentiation to a podocyte fate in the aged mouse kidney. Aging (Albany NY). 2020; 12(17):17601-17624. PMC: 7521511. DOI: 10.18632/aging.103788. View

2.
Vikse B, Irgens L, Leivestad T, Hallan S, Iversen B . Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol. 2007; 19(1):151-7. PMC: 2391041. DOI: 10.1681/ASN.2007020252. View

3.
Wintour E, Moritz K, Johnson K, Ricardo S, Samuel C, Dodic M . Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol. 2003; 549(Pt 3):929-35. PMC: 2342989. DOI: 10.1113/jphysiol.2003.042408. View

4.
Harindhanavudhi T, Parks A, Mauer M, Caramori M . Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients. Am J Nephrol. 2015; 41(4-5):277-83. PMC: 4514533. DOI: 10.1159/000381992. View

5.
. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225):709-733. PMC: 7049905. DOI: 10.1016/S0140-6736(20)30045-3. View